86 related articles for article (PubMed ID: 2828953)
1. Delta and kappa opioid receptors in the rabbit ear artery.
Berzetei IP; Fong A; Duckles SP
NIDA Res Monogr; 1986; 75():105-8. PubMed ID: 2828953
[TBL] [Abstract][Full Text] [Related]
2. Characterization of kappa and delta opioid receptors in isolated organs by using type/subtype selective agonists and antagonists.
Makó E; Rónai AZ
Med Sci Monit; 2001; 7(3):350-6. PubMed ID: 11386008
[TBL] [Abstract][Full Text] [Related]
3. Use of the mouse vas deferens to determine mu, delta, and kappa receptor affinities of opioid antagonists.
Cohen ML; Mendelsohn LG; Mitch CH; Zimmerman DM
Receptor; 1994; 4(1):43-53. PubMed ID: 8038706
[TBL] [Abstract][Full Text] [Related]
4. Characterization of rabbit ear artery opioid receptors using a delta-selective agonist and antagonist.
Berzetei IP; Yamamura HI; Duckles SP
Eur J Pharmacol; 1987 Jul; 139(1):61-6. PubMed ID: 2820755
[TBL] [Abstract][Full Text] [Related]
5. Opioid profiles of Cys2-containing enkephalin analogues.
Pencheva N; Milanov P; Vezenkov L; Pajpanova T; Naydenova E
Eur J Pharmacol; 2004 Sep; 498(1-3):249-56. PubMed ID: 15364002
[TBL] [Abstract][Full Text] [Related]
6. Cross-protection of mu and delta opioid receptors in the mouse vas deferens.
Sheehan MJ; Hayes AG; Tyers MB
NIDA Res Monogr; 1986; 75():85-8. PubMed ID: 2829013
[TBL] [Abstract][Full Text] [Related]
7. Receptor preference of dynorphin A fragments in the mouse vas deferens determined by different techniques.
Schulz R; Wüster M; Herz A
J Pharmacol Exp Ther; 1984 Jul; 230(1):200-4. PubMed ID: 6146706
[TBL] [Abstract][Full Text] [Related]
8. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
[TBL] [Abstract][Full Text] [Related]
9. Dihydromorphine-peptide hybrids have mu receptor antagonistic and delta receptor agonistic activity on the mouse vas deferens and bind with high affinity to opioid receptors in rat brain.
Smith CB; Medzihradsky F; Woods JH
NIDA Res Monogr; 1986; 75():189-92. PubMed ID: 2828970
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the opioid activity of CAM and kappa agonists.
Furst S; Friedmann T; Kovacs A; Wagner T
NIDA Res Monogr; 1986; 75():224-7. PubMed ID: 2828975
[TBL] [Abstract][Full Text] [Related]
11. Delta receptors in the rat vas deferens.
Smith CF; Carter A
Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):181-92. PubMed ID: 3030209
[TBL] [Abstract][Full Text] [Related]
12. Characterization of kappa opioid receptors in the rabbit ear artery.
Berzetei IP; Fong A; Yamamura HI; Duckles SP
Eur J Pharmacol; 1988 Jul; 151(3):449-55. PubMed ID: 2905660
[TBL] [Abstract][Full Text] [Related]
13. Actions of mu, delta and kappa opioid agonists and antagonists on mouse primary afferent neurons in culture.
Werz MA; Grega DS; MacDonald RL
J Pharmacol Exp Ther; 1987 Oct; 243(1):258-63. PubMed ID: 2822900
[TBL] [Abstract][Full Text] [Related]
14. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic evaluation of a cyclic somatostatin analog with antagonist activity at mu opioid receptors in vitro.
Shook JE; Pelton JT; Wire WS; Hirning LD; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1987 Mar; 240(3):772-7. PubMed ID: 2882015
[TBL] [Abstract][Full Text] [Related]
16. Effects of structural modifications of N-CPM-normorphine derivatives on agonist and antagonist activities in isolated organs.
Riba P; Tóth Z; Hosztafi S; Friedmann T; Fürst S
Acta Biol Hung; 2003; 54(2):177-81. PubMed ID: 14535623
[TBL] [Abstract][Full Text] [Related]
17. Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine.
Negus SS; Burke TF; Medzihradsky F; Woods JH
J Pharmacol Exp Ther; 1993 Nov; 267(2):896-903. PubMed ID: 8246165
[TBL] [Abstract][Full Text] [Related]
18. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
19. Proglumide exhibits delta opioid agonist properties.
Rezvani A; Stokes KB; Rhoads DL; Way EL
Alcohol Drug Res; 1987; 7(3):135-46. PubMed ID: 3030338
[TBL] [Abstract][Full Text] [Related]
20. Dynorphin A(1-8): stability and implications for in vitro opioid activity.
Bell KM; Traynor JR
Can J Physiol Pharmacol; 1998 Mar; 76(3):325-33. PubMed ID: 9673796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
